A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer.

The application of EMDA-enhanced MMC has been studied at different times of disease and with different administration protocols. It appears to delay bladder tumor recurrence and progression in certain populations. However, the methodological limitations of the published studies prevent definitive conclusions about its efficacy.